… the development of cardiorenal pathophysiology. Currently several biomarkers have been
… definition and classification of CRS as well as biomarkers for CRS diagnosis and prognosis. …

… It seems timely to revisit the value of CRS biomarkers in a pathophysiology-centered …
describing the use of 44 biomarkers and 4 proteomic panels. All biomarkers are involved in at least …

… , might represent a promising strategy in the management of cardiorenal syndrome due to
… the pathophysiology of cardiorenal syndrome in adults, as well as the utility of biomarkers in …

… with biomarkers that could be the next target for diagnosis, treatment, and prognosis in
cardiorenal syndrome. … function and in the pathophysiology of cardiorenal syndrome in diabetes. …

… From new aspects of classic biomarkers to microRNAs, this review aimed at a 360-degree …
Based on the pathophysiology of the CRS, much attention was paid to AVP as a biomarker. …

… integrative concept (Figure 5) that combines documentation of fibrotic pathophysiology
using companion diagnostic biomarkers with therapeutic management aimed at potential …

… pathophysiology of cardiorenal syndrome in light of recently obtained data. Renal tubular
biomarkers may have the potential to be a predictor of heart failure and cardiorenal syndrome. …

… pathophysiology in the setting of CRS I. Herein, we briefly review some emerging biomarkers,
… These biomarkers may help early detecting, differential diagnosis, assessing disease …

… of cardiorenal syndrome based on its pathophysiology is … strategies, notably cardiorenal
biomarkers that may help with … treatment strategies for cardiorenal syndrome and, through a …

The earliest mention of the term cardiorenal syndrome (CRS) came about from a 2004
National Heart, Lung, and Blood Institute Working Group conference evaluating the interaction …